Author Archive: AZBio
Biodesign Team using tobacco to thwart West Nile virus
An international research group, led by Arizona State University professor Qiang “Shawn” Chen, has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus and other pathogens.Continue reading
BIO Announces Kay Holcombe to Join as Senior Vice President, Science Policy
Cord Blood Registry’s Newborn Possibilities Program
25% of all the stem cell units released for use by CBR have been collected under their free access initiativeContinue reading
TGen and Scottsdale Healthcare cancer expert Dr. Von Hoff receives Hope Funds award
Dr. Daniel D. Von Hoff, who has been instrumental in developing numerous new cancer treatments, is among this year’s recipients of the Award of Excellence from the Hope Funds for Cancer Research.Continue reading
Nearly 40 New Medicines in Development for Parkinson’s Disease
Washington, D.C. (March 24, 2014) — America’s biopharmaceutical research companies currently are developing 37 innovative new medicines to help the estimated 10 million people worldwide who are living with Parkinson’s disease. These medicines in development – all either in clinical trials or under review by the Food and Drug Administration (FDA) – include 23 for Parkinson’s disease, 11 for related conditions and 3 diagnostics, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).Continue reading
ASU scientist Roy Curtiss receives Lifetime Achievement Award from ASM
Roy Curtiss III, a scientist at the Biodesign Institute at Arizona State University, has been selected as the 2014 recipient of the Lifetime Achievement Award from the American Society for Microbiology (ASM).Continue reading
HCR 2005 – “Right to Try” Won’t Benefit Patients
While well intentioned, State “Right to Try” bills are fraught with false hope and dangerous side effects.Continue reading
Castle Biosciences’ Non-Invasive Gene Expression Profile Test Shown to Identify Sentinel Lymph Node Negative Melanoma Patients at High Risk of Metastasis
Data presented at the Latest in Dermatology Research Symposia session of 72nd Annual Meeting of the American Academy of DermatologyContinue reading
TGen-led study discovers genetic cause of rare type of ovarian cancer
Scientific breakthrough could lead to new cancer treatments; study inspired by memory of 22-year-old patientContinue reading